KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Retained Earnings (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Retained Earnings for 3 consecutive years, with -$2.9 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Retained Earnings rose 99.93% year-over-year to -$2.9 million, compared with a TTM value of -$2.9 million through Sep 2023, up 99.93%, and an annual FY2022 reading of -$4.4 billion, down 91.38% over the prior year.
  • Retained Earnings was -$2.9 million for Q3 2023 at Ginkgo Bioworks Holdings, down from -$1.3 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $5.0 million in Q1 2021 and bottomed at -$4.6 billion in Q1 2023.
  • Average Retained Earnings over 3 years is -$2.1 billion, with a median of -$2.3 billion recorded in 2021.
  • The sharpest move saw Retained Earnings tumbled 57936.04% in 2022, then skyrocketed 99.96% in 2023.
  • Year by year, Retained Earnings stood at -$2.3 billion in 2021, then crashed by 91.38% to -$4.4 billion in 2022, then skyrocketed by 99.93% to -$2.9 million in 2023.
  • Business Quant data shows Retained Earnings for DNA at -$2.9 million in Q3 2023, -$1.3 million in Q2 2023, and -$4.6 billion in Q1 2023.